Potential Gains Using High-Energy Protons for Therapy of Malignant Tumours

REFERENCES

• Holsti LR. Development of clinical radiotherapy since 1896. Acta Oncol 1995; 34: 995–1003.
   PubMed Web of Science ®Google Scholar
• Allt WEC. Supervoltage radiation treatment in advanced cancer of the uterine cervix. Can Med Assoc J 1969; 100: 792.
   PubMed Web of Science ®Google Scholar
• Hayman J, Weeks J, Mauch P. Economic analyses in health care: an introduction to the methodology with an emphasis on radiation therapy. Int .1- Radiat Oncol Biol Phys 1996; 35: 827–41.
   Google Scholar
• Kutcher GJ, Burman C. Calculation of complication proba-bility factors for non-uniform normal tissue irradiation: the effective volume method. Int .1- Radiat Oncol Biol Phys 1989; 16: 1623–30.
   PubMed Web of Science ®Google Scholar
• Webb S, Nahum AK. A model for calculating tumour control probability in radiotherapy including the effect of inhomoge-neous distributions of dose and clonogenic cell density. Phys Med Biol 1993; 37: 653–66.
   Web of Science ®Google Scholar
• Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res 1985; 104: 13–9.
   Web of Science ®Google Scholar
• Källman P, Lind BK, Brahme A. An algorithm for maximiz-ing the probability of complication free tumour control in radiotherapy. Phys Med Biol 1992; 37: 871–90.
   Google Scholar
• Grusell E, Montelius A, Brahme A, Rikner G, Russell K. A general solution to charged particle beam flattening using an optimized dual-scattering-foil technique, with application to proton therapy beams. Phys Med Biol 1994; 39: 2201–16.
   Google Scholar
• Urie MM, Goitein M. Variable versus fixed modulation of proton beams for treatments in the cranium. Med Phys 1989; 16: 593–601.
   PubMed Web of Science ®Google Scholar
• Bonnett DE. Current developments in proton therapy: a review. Phys Med Biol 1993; 38: 1371–92.
   PubMed Web of Science ®Google Scholar
• Slater JM, Archambeau JO, Dicello JF, Slate JD. Proton beam irradiation: toward routine clinical utilization. In: Amaldi U, Larson B, eds. Hadrontherapy in Oncology. Zurich: Elsevier Science B.V, 1994: 130–7.
   Google Scholar
• Webb S. Optimizing the planning of intensity-modulated ra-diotherapy. Phys Med Biol 1994; 39: 2229–46.
   PubMed Web of Science ®Google Scholar
• Blomquist E, Russel KE, Stenerlow B, et al. Relative biologi-cal effectiveness of intermediate energy protons. Comparison with 60Co gamma-irradiation using two cell lines. Radiother Oncol 1993; 98: 44–51.
   Google Scholar
• Russell K, Grusell E, Montelius A. Dose calculations in proton beams: range straggling and energy scaling. Phys Med Biol 1995; 40: 1031–43.
   Google Scholar
• Urie M, Goitein M, Holley WR, Chen G. Degradation of the Bragg peak due to inhomogeneities. Phys Med Biol 1986; 31: 1–15.
   PubMed Web of Science ®Google Scholar
• Petti P. Differential-pencil-beam dose calculations for charged particles. Med Phys 1992; 19: 137–49.
   PubMed Web of Science ®Google Scholar
• Bonnelli G, Canzi C, Casamassima F, et al. Clinical indica-tions and estimates of patient affiux in a centre for proton therapy. Milan: Report of TERA Working Group, 1993.
   Google Scholar
• Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst 1992; 84: 155–64.
   PubMed Web of Science ®Google Scholar
• Austin JP, Urie MM, Cardenosa G, Munzenrider JE. Proba-ble causes of recurrence in patients with chordoma and chon-drosarcoma of the base of skull and cervical spine. Int .1-Radiat Oncol Biol Phys 1993; 25: 439–44.
   PubMed Web of Science ®Google Scholar
• McAllister B, Archambeau JO, Nguyen MC, et al. Proton therapy for pediatric cranial tumors: preliminary report on treatment and disease-related morbidities. Int J Radiat Oncol Biol Phys 1997; 39: 455–60.
   PubMed Web of Science ®Google Scholar
• Jansson T, Lindman H, Nygard K. Radiotherapy of breast cancer after breast conserving surgery: an improved technique using mixed electron-photon beams with a multileaf collima-tor. Radiother Oncol 1998; 46: 83–9.
   Google Scholar
• Overgaard M, Hansen PS, Overgaard J. Postoperative radio-therapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
   Google Scholar
• Miralbell R, Bleher A, Huguenin P. Pediatric medulloblas-toma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 1997; 37: 523–9.
   Google Scholar
• Suit HD, Russel NO. Radiation therapy of soft tissue sarco-mas. Cancer 1975; 36: 759–64.
   PubMed Web of Science ®Google Scholar
• FrOdin JE, Jonsson E, Moller T, Werko L. Radiotherapy in Sweden--a study of present use in relation to the literature and estimate of future trends. Acta Oncol 1996; 35: 967–80.
   PubMed Web of Science ®Google Scholar
• Leibel SA, Ling CC, Kutcher GJ, Mohan R, Gordon-Cordo C, Fuhs Z. The biological basis for conformal three-dimen-sional radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 1709–19.
   Google Scholar
• Davey TJ. Physical aspects of conformation therapy using computer-controlled tracking units. In: Ortan CG, ed. Pro-gress in medical radiation physics, vol. II. New York: Plenum, 1985.
   Google Scholar
• Joiner MC, Johns H. Renal damage in the mouse: the re-sponse to very small doses per fraction. Radiat Res 1988; 114: 385–98.
   PubMed Web of Science ®Google Scholar
• Nickers P, Kunkler I, Scalliet P. Modern brachytherapy: current state and future prospects. Eur J Cancer 1997; 33: 1747–51.
   Google Scholar
• Archambeau JO, Slater JD, Slater JM, Tangeman R. Role for proton-beam irradiation in treatment of pediatric CNS malig-nancies. Int .1- Radiat Oncol Biol Phys 1992; 22: 287–94.
   PubMed Web of Science ®Google Scholar
• Tatsuzaki H, Gregoire V, Linggood R. Comparative treat-ment planning: proton vs x-ray beams against glioblastoma multifoRme. Int .1- Radiat Oncol Biol Phys 1992; 22: 265–74.
   Google Scholar
• Miralbell R, Lomax A, Bortfeld T, Rouzaud M, Carrie C. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: reduc-tion of the supratentorial target volume. Int .1- Radiat Oncol Biol Phys 1997; 38: 477–84.
   Google Scholar
• Miralbell R, Lomax A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primi-tive neuro-ectodermal tumors: Spinal theca irradiation. Int .1-Radiat Oncol Biol Phys 1997; 38: 805–11.
   Google Scholar
• Miralbell R, Crowell C, Suit H. Potential improvement of three dimensional treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int .1- Radiat Oncol Biol Phys 1997; 22: 305–10.
   Google Scholar
• Slater JM, Slater JD, Archambeau JO. Carcinoma of the tonsillar region: potential for use of proton-beam therapy. Int J Radiat Oncol Biol Phys 1992; 22: 311–20.
   Google Scholar
• Langer M, Kijewski P. CCRT for non-small cell lung cancer: sensitivity of clinical gains to organ tolerance restrictions. Int J Radiat Oncol Biol Phys 1992; 22: 325–32.
   PubMed Web of Science ®Google Scholar
• Isacsson U, Lennernds B, Grusell E, Jung B, Montelius A, Glimelius B. Comparative treatment planning betvveen pro-ton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys 1998 (In press).
   Google Scholar
• Isacsson U, Hagberg H, Johansson KA, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conven-tional radiation beams for paraspinal tumours. Radiother Oncol 1997; 45: 63–70.
   PubMed Web of Science ®Google Scholar
• Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and x-ray therapy in locally advanced rectal cancer. Radiother Oncol 1996; 41: 263–72.
   PubMed Web of Science ®Google Scholar
• Lee M, Wynne C, Webb S, Nahum AK, Deamaley D. A comparison of proton and megavoltage x-ray treatment plan-ning for prostate cancer. Radiother Oncol 1994; 33: 239–53.
   Google Scholar
• Smit B. Prospects for proton therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992; 22: 349–54.
   PubMed Web of Science ®Google Scholar
• Levin CV. Potential for gain in the use of proton-beam boost to the para-aortic lymph nodes in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992; 22: 355–60.
   PubMed Web of Science ®Google Scholar
• Sandison GA, Papiez E, Bloch C, Morphis J. Phantom assess-ment of lung dose from proton arc therapy. Int J Radiat Oncol Biol Phys 1997; 38: 891–897.
   PubMed Web of Science ®Google Scholar
• Gademan G. Socioeconomic aspects of hadron therapy. In: Umaldi U, Larsson B, eds. Hadron therapy in oncology. Int Congr Ser 1077: Excerpta Medica, 1994: 59–66.
   Google Scholar